Cell and Gene Therapy Europe | Berlin 2017

Meet the future of ATMP commercialisation at Europe's premier partnering event at Phacilitate's 3rd Cell and Gene Therapy Europe. Join 400 industry decision-makers and key external stakeholders at the event which defines the strategic roadmap to European success for cell and gene therapy developers, ensuring European patients gain access to the game-changing biotherapeutics of tomorrow. Be a part of the only European event that offers extensive coverage of ATMP RandD, manufacturing and regulatory issues and challenges, translating innovation to global success. For sponsorship enquiries visit: http://www.cgteurope.com/forms/sponsorship-enquiry